Share Your Feedback
Genesis Molecular AI
Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines.
Funding
Growth Stage
Current Stage
$200M
Recent Funding
$256.1M
Total Funding
Leadership Team
Evan Feinberg
Founder and CEO
Sergey Edunov
Chief Technology Officer